A Clinical Trial Assessing Safety of MF101 for Hot Flushes
Status:
Unknown status
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
This Phase 1, open label, randomized clinical trial will enroll 40 generally healthy,
postmenopausal women aged 40-65 years old. Women will be randomized to one of two oral doses
of MF101 for 4 weeks. Participants will be recruited at 3 clinical sites in the United
States.